Patent Cliff
Jun 13, 2025
Navigating the Loss of Exclusivity: Big Pharma’s New Playbook
The Patent Cliff Returns: Can Big Pharma Innovate Fast Enough to Stay on Top? For decades, blockbuster drugs have fueled the pharmaceutical industry’s golden age. But as the 2020s unfold, a familiar threat is resurfacing with unprecedented intensity: the Loss of Exclusivity (LOE). With patents on multibillion-do...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
